Contact Information

Call us at: (614) 355-6377

Email Nicole Skinner, MD, PhD

Infectious Diseases700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Nicole Skinner

Research

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Biography

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Academic and Clinical Areas

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

Education

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Contact Information

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Call us at: (614) 355-6377

Email Nicole Skinner, MD, PhD

Infectious Diseases700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Nicole Skinner

Research

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Biography

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Academic and Clinical Areas

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

Education

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Contact Information

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Call us at: (614) 355-6377

Email Nicole Skinner, MD, PhD

Infectious Diseases700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Nicole Skinner

Contact Information

  • Call us at:
  • (614) 355-6377
  • Email Nicole Skinner, MD, PhD
  • Infectious Diseases700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Nicole Skinner

Research

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Research

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Research

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection. Publications

                  Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  

                


                  Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.

                


                  Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.

                


                  Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 

                


                  Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

Dr. Skinner’s research focuses on B cell immunity to hepatitis C, with a special interest in how differences in B cell receptor sequence shape the response to infection.

Interests

Hepatitis C; Humoral immunity

Lab(s)

Center for Vaccines and Immunity

  • Hepatitis C; Humoral immunity

  • Center for Vaccines and Immunity

                    Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;  



                Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.



                Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.



                Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131: 



                Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

View More Publications

  • Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022 Mar 29;
  • Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE Jr, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 Jan; 18: e1010179.
  • Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4+ T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4+ T Cell Recovery. Viral Immunol. 2021 Nov; 34: 622-631.
  • Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest. 2021 Apr 1; 131:
  • Skinner NE, Bailey JR. Broadly neutralizing antibodies against hepatitis C virus: location, location, location. J Hepatol. 2020 Apr; 72: 604-606.

Biography

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Biography

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Biography

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center. Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Nicole Skinner, MD, PhD, is a principal investigator in the Center for Vaccines and Immunity at Nationwide Children’s Hospital and an Assistant Professor in the department of Pediatrics at the Ohio State University College of Medicine. She is also an infectious diseases physician at the Ohio State University Wexner Medical Center.

Dr. Skinner received her MD and PhD degrees from the University of Minnesota. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Johns Hopkins Hospital.

Academic and Clinical Areas

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

Academic and Clinical Areas

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

Academic and Clinical Areas

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

Center for Vaccines and Immunity

Principal Investigator

Primary Department

Infectious Diseases

  • Center for Vaccines and Immunity
  • Principal Investigator
  • Primary Department
  • Infectious Diseases

Education

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Education

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Education

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Fellowship

Johns Hopkins Hospital

Date Completed: 06/30/2021

Residency

Beth Israel Deaconess Medical Center

Date Completed: 06/30/2018

Medical School

University of Minnesota

Date Completed: 05/08/2015

Contact Information

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Infectious Diseases

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)

Call us at: (614) 355-6377

Email Nicole Skinner

                    700 Children's Dr.Columbus, OH 43205 (map)
  • Call us at:
  • (614) 355-6377
  • Email Nicole Skinner
  • 700 Children’s Dr.Columbus, OH 43205 (map)